Gliclazide Sustained-Release Tablets 30mg (Darentang) – Factory wholesale For Laboratory Research Use Only

Gliclazide Sustained-Release Tablets 30mg (Darentang) – Factory wholesale For Laboratory Research Use Only

$2.00

Gliclazide Sustained-Release Tablets (30mg) are used in laboratory research involving insulin secretion, beta-cell response, and glucose regulation in Type 2 diabetes models. Manufactured by Darentang New Xin Pharmaceutical Factory. Not for human or veterinary use.?Please consult staff for price, other specifications and uses?

EMI starting from $0.00/month - View Plans
Compare

Description

Gliclazide is a second-generation sulfonylurea that stimulates insulin release from pancreatic beta-cells by modulating ATP-sensitive potassium channels. The sustained-release (SR) formulation provides controlled exposure for extended biological modeling.

Each tablet delivers 30mg of gliclazide, with 15 tablets per blister and two blisters per box (30 tablets total). Manufactured by Tianjin Zhongxin Pharmaceutical Group Co., Ltd. – New Xin Pharmaceutical Factory under NMPA registration H20065582. Product code: 86900964000200.

Strictly for laboratory use only. Not approved for human or veterinary applications.


Gliclazide Sustained-Release Product Specifications

ParameterDetails
Product NameGliclazide Sustained-Release Tablets
Generic NameGliclazide SR
CAS Number21187-98-4
Molecular FormulaC15H21N3O3S
Molecular Weight323.41?g/mol
Dosage FormOral tablet (sustained release)
Strength30mg per tablet
Quantity15 tablets × 2 blisters (30 tablets per box)
Approval NumberH20065582 (China NMPA)
Product Code86900964000200
ManufacturerTianjin Zhongxin Pharmaceutical (Darentang New Xin Factory)
Barcode6941155701272
Intended UseFor laboratory research only
Storage ConditionsStore in a dry place below 25°C, avoid humidity and sunlight

Gliclazide Sustained-Release Mechanism & Research Applications

Gliclazide stimulates insulin secretion by inhibiting potassium channels in pancreatic beta cells, causing calcium influx and subsequent insulin release. It is a useful compound in studies related to:

  • Type 2 diabetes mellitus modeling

  • Glucose metabolism and insulin resistance research

  • Sulfonylurea receptor pharmacology

  • Pancreatic beta-cell functional assays

  • Glycemic control simulation in animal models


Safety & Handling

  • Use Restriction: For laboratory research use only

  • Protective Equipment: Gloves, lab coat, safety glasses

  • Storage: Store sealed below 25°C

  • Disposal: Dispose of via standard laboratory chemical waste procedures


Research Use Disclaimer

This product is intended solely for laboratory research. It is not approved for human, diagnostic, therapeutic, or veterinary use. Misuse may involve safety or regulatory risks. Researchers should follow proper biosafety and disposal protocols.

Additional information

Weight1 kg
Dimensions26 × 23 × 26 cm

Reviews

There are no reviews yet.

Be the first to review “Gliclazide Sustained-Release Tablets 30mg (Darentang) – Factory wholesale For Laboratory Research Use Only”

Your email address will not be published. Required fields are marked *

Q1: Can Gliclazide SR be used in clinical applications?

A1: No. This product is strictly for laboratory and experimental research purposes.

Q2: Is bulk purchasing available?

A2: Yes. We offer both wholesale and retail options. Please contact us for tiered pricing.

Q3: Are COA and SDS documents provided?

A3: Yes, Certificate of Analysis (COA) and Safety Data Sheet (SDS) are available upon request.

Q4: What research fields use this compound?

A4: Common in endocrinology, pharmacology, and preclinical diabetes research.

Q5: How is the product packaged?

A5: Each box contains 2 blister packs, 15 tablets each, 30mg per tablet.


EMI Options

Select at least 2 products
to compare